Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,622 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04363684Recruiting
Study of frontotemporal dementia and related syndromes over time
This study follows people with frontotemporal dementia (FTLD) and related conditions, and collects health and (for some people) body fluid information, to understand how these illnesses change over time. It may help researchers track disease signs and find better ways to measure progression.
Birmingham, AlabamaAges 18 years+ - NCT07232550Recruiting
Breathing study for children needing bronchoscopy
This study collects samples (like fluid from the lungs) during a planned bronchoscopy to look for new ways to understand and predict children's breathing problems. It might help if your child already needs this procedure for a medical reason.
WarsawAges Up to 17 years - NCT07556341Recruiting
Ultrasound Imaging at Free Clinics in Indianapolis
This study tests whether quick ultrasound imaging (a safe, painless scanning tool) can help doctors better diagnose and treat patients at free clinics in Indianapolis. Researchers want to see if point-of-care ultrasound—performed right in the clinic—improves care for patients without insurance or regular doctors.
Indianapolis, IndianaAges 18 years+ - NCT06972056RecruitingPhase 4
Comparing migraine prevention drugs: atogepant, propranolol, topiramate
This study compares three common migraine prevention medications to see which works best. You might be able to join if you have migraines at least 4 days a month and haven't taken these specific drugs before.
Flagstaff, ArizonaAges 18–70 - NCT06422338Recruiting
Fast test to predict infection risk in febrile children
This study is testing a new, fast test to better identify which young children with fever are at risk for serious illness. If your child is eligible, they will be part of a group that helps doctors decide how to treat febrile children more accurately.
Lambaréné, Moyen-Ogooué ProvinceAges 2 months–5 years - NCT05514106Enrolling by invitationPhase 4
MIBG heart scan study for aging and neurologic conditions
This Phase 4 study tests how an iodine-based heart scan (a special imaging test) works in people with certain neurologic diagnoses and aging-related conditions. It may help researchers better understand the heart-brain connection in these disorders and improve future care.
Rochester, MinnesotaAges 40–90 - NCT07734389Recruiting
Genetic breast cancer risk test for DORA study participants
This trial offers genetic testing to women who took part in the earlier DORA study and were found to have a moderately increased or high risk of breast cancer. It aims to better understand genetic risk factors to improve early detection and prevention.
LjubljanaAges 53–54 - NCT06729996RecruitingPhase 2
Comparing two diabetes medicines for pancreatitis-related diabetes
This trial tests whether pioglitazone or empagliflozin is better at managing diabetes caused by chronic or recurrent pancreatitis. You will take one of these pills daily for 6 months and track your blood sugar and ketones at home. The goal is to find a safer, more effective treatment for this type of diabetes.
Rochester, MinnesotaAges 18–80 - NCT07149701Recruiting
Ventricular Tachycardia patient registry study
This study is for adults with ventricular tachycardia (a fast heart rhythm) who also have structural heart disease. It will track your health over time to learn more about how this condition is managed.
BeijingAges 18 years+ - NCT07730515RecruitingPhase 1/Phase 2
Study of XNW5004 plus chemo for untreated T-cell lymphoma
This trial tests a new drug called XNW5004 combined with standard chemotherapy for people who have just been diagnosed with peripheral T-cell lymphoma and haven't had treatment yet. The goal is to see if adding XNW5004 helps more than chemotherapy alone.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07450911RecruitingPhase 1
Mitral valve replacement with the ReValve system
This study is for people with severe mitral valve leakage (mitral regurgitation) who may need a valve replacement. It tests whether the ReValve system is safe and can help improve symptoms and heart function.
TbilisiAges 18 years+ - NCT07680452Recruiting
High-fiber diet and short-term fasting for melanoma patients on immunotherapy
This trial tests if a high-fiber diet and occasional short-term fasting can help melanoma patients respond better to immunotherapy. It aims to improve treatment outcomes by changing gut health.
Berlin, State of BerlinAges 18 years+ - NCT04371445RecruitingPhase 4
Dextenza drops after eye surgery to reduce post-op pain
This trial studies whether Dextenza (a steroid pain-relief eye insert) can improve comfort after a specific type of retina surgery (pars plana vitrectomy). It looks at people getting surgery for conditions like macular hole, epiretinal membrane, or vitreomacular traction.
Cleveland, OhioAges 18 years+ - NCT06802172Recruiting
Timing meals during cancer treatment for Alaska Native patients
This study tests whether scheduling meals at specific times of day can improve how patients feel during cancer treatment. It is for Alaska Native or American Indian people with certain cancers (rectal, HER2+ or triple negative breast, or other solid tumors) who are receiving neoadjuvant (before surgery) or adjuvant (after surgery) therapy.
Anchorage, AlaskaAges 21 years+ - NCT06704672Recruiting
Effect of a new glucose sensor on blood sugar control in diabetes
This study compares a continuous glucose monitor (CGM) to fingerstick testing for people with type 1 or type 2 diabetes who give themselves insulin injections. It aims to see if using the sensor helps increase the time blood sugar stays in a healthy range.
GdanskAges 18 years+ - NCT07141342Recruiting
Bed scale weight loss program for wheelchair users
This study tests if using a special bed scale helps wheelchair users lose more weight during a weight loss program. Participants will follow a weight loss plan, and half will get the bed scale to track their weight at home.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT06667453RecruitingPhase 2
PGN-EDODM1 for myotonic dystrophy type 1
This study tests an experimental drug called PGN-EDODM1 for people with myotonic dystrophy type 1 (DM1). The goal is to see if it can help reduce symptoms like muscle stiffness (myotonia).
Calgary, AlbertaAges 16–65 - NCT07600788RecruitingPhase 1
Liver Function and Safety Study of AHB-137 Injection
This study tests how a new investigational drug called AHB-137 moves through your body and affects safety in people with mild-to-moderate liver problems compared to people with normal liver function. The goal is to understand if the drug works safely in people whose livers don't work as well as they should.
Chongqing, Chongqing MunicipalityAges 18–65 - NCT07084012RecruitingPhase 2
Stem cell treatment for recent stroke
This trial tests whether a single infusion of umbilical cord stem cells can help people recover from a recent ischemic stroke (stroke caused by a clot). It is for patients who have had their stroke within the last 72 hours and have moderate to severe symptoms.
Beijing, Beijing MunicipalityAges 18–75 - NCT07255404RecruitingPhase 2
Testing pumitamig with chemotherapy for untreated pancreatic cancer
This trial tests an experimental drug called pumitamig combined with standard chemotherapy for people with advanced pancreatic cancer that has spread and has not been treated yet. The goal is to see if this combination is safe and effective.
Bedford ParkAges 18 years+ - NCT07216235RecruitingPhase 3
Long-term study of saroglitazar for PBC with cirrhosis
This study tests a new drug called saroglitazar to see if it can improve long-term outcomes in people with primary biliary cholangitis (PBC) who have cirrhosis. It may be an option if you are already on UDCA or cannot take it, and if your liver function tests meet certain levels.
Marietta, GeorgiaAges 18 years+ - NCT07730827Recruiting
Community program for better heart failure care
This study tests whether a program that connects you with community health workers and your care team can help you manage heart failure better. It looks at things like your living situation, medical needs, and social support to make your care more fair and personalized.
Rochester, MinnesotaAges 18 years+ - NCT06567340Recruiting
AI-guided care for depression in talking therapies
This trial tests whether an AI tool can help therapists choose the best treatment for depression. If you are 18 or older and have significant depression symptoms (PHQ-9 score of 10 or more), you may be able to join if you are already being treated at a participating Talking Therapies service.
Darlington, DurhamAges 18 years+ - NCT07731334Recruiting
Memory problems in non-neurology rehab patients
This study looks at how common mild cognitive impairment and dementia are in people staying in rehabilitation units for heart, lung, or orthopedic problems. It aims to understand memory and thinking issues that may be overlooked in these settings.
Florence, FIAges 45 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,622 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.